Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects

Area of Science:

• Neuroimmunology
• Neurology
• Immunology

Background:

• Neuroimmunological disorders result from complex nervous and immune system interactions, causing conditions like Alzheimer's, Parkinson's, and multiple sclerosis.
• These diseases involve immune-mediated damage or inflammation in nervous tissue, leading to significant neurological deficits.
• Increasing global aging populations project a sharp rise in neuroimmunological diseases, posing a growing public health and economic challenge.

Purpose of the Study:

• To summarize the current understanding of neuroimmunological disorders.
• To highlight the limitations of current therapies and the potential of emerging treatment strategies.
• To emphasize the need for further research into molecular and genetic mechanisms for developing innovative therapies.

Main Methods:

• Review of existing literature on neuroimmunological disorders.
• Analysis of current therapeutic approaches and their limitations.
• Exploration of emerging treatments, including nanomedicine and natural products.

Main Results:

• Neuroimmunological disorders are a significant and growing global health concern, particularly with aging populations.
• Current treatments primarily manage symptoms, but novel strategies like nanomedicine and natural compounds show promise for targeted delivery and neuroprotection.
• Advanced research into underlying mechanisms is crucial for developing curative therapies.

Conclusions:

• Neuroimmunological disorders represent a complex challenge requiring innovative therapeutic approaches.
• Nanomedicine and natural products offer promising avenues for more effective and targeted treatments.
• Continued research into molecular pathways and genetic factors is essential for advancing neurological healthcare and achieving disease prevention or cures.